ERRATUM article

Front. Neurol., 03 November 2021

Sec. Headache and Neurogenic Pain

Volume 12 - 2021 | https://doi.org/10.3389/fneur.2021.793620

Erratum: Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus

This article is an erratum on:

  1. Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus

    1. Read original article
Frontiers Production Office Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus

by Tziakouri, A., Tsangari, H., and Michaelides, C. (2021). Front. Neurol. 12:687697. doi: 10.3389/fneur.2021.687697

Due to a production error, there was an error in affiliation 1 for author Andria Tziakouri. Instead of “Department of Neurology, Medical School, University of Nicosia, Nicosia, Cyprus,” it should be “Department of Neurology, American Medical Center, Nicosia, Cyprus.”

The publisher apologizes for this mistake. The original version of this article has been updated.

Keywords: erenumab, chronic migraine, quality of life, MSQ V2.1, Cyprus, treatment failure

Citation: Frontiers Production Office (2021) Erratum: Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus. Front. Neurol. 12:793620. doi: 10.3389/fneur.2021.793620

Received: 12 October 2021; Accepted: 12 October 2021;
Published: 03 November 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.